MedPath

Trial to study the effects of Sertaconazole and electrocautery in localized Tinea Corporis

Not Applicable
Conditions
Health Condition 1: B354- Tinea corporis
Registration Number
CTRI/2021/03/032335
Lead Sponsor
Dept of dermatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) localised tinea corporis

2) at least 2 lesions

8) willing to be photographed

Exclusion Criteria

1) pregnant and lactating patients

2) patients with pacemakers

3) patients with keloidal and/or hyperpigmentation tendencies

4) patients with hypersensitivity to 2% sertaconazole

5) patients with individual lesions >5 cm

6) patients on systemic antifungal in past 3 months

7) patients on topical antifungal 1 week prior to recruitment

8) disseminated tinea

9) uncontrolled diabetes

10) immunocompromised like HIV-AIDS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath